haematobium was declared as Group 1 (extensively proven) carcinogens by the WHO International Agency for Research on Cancer (IARC) Working Group on the Evaluation of Carcinogenic Risks to Humans in 2009
Water should be the primary fluid of choice
As your body adapts to a new eating pattern, there is an opportunity to optimize your health through a supportive supplement regimen
The effectiveness of L-Lysine HCl may vary from person to person, and it is essential to follow the dosage and administration guidelines provided by healthcare professionals
Mr Mfazo Hove Featured in Newsweek: GLP-1 Medications and Vision Loss Posted Medically Reviewed by: Mr Mfazo Hove, Consultant Ophthalmic Surgeon Author: Chris Dunnington Published: July 16, 2026 Last Updated: July 16, 2026 Mr Mfazo Hove, Consultant Ophthalmic Surgeon and Medical Director of Blue Fin Vision, has been invited by Newsweek to comment on new international research linking GLP-1 medications to a rare optic nerve condition that can cause sudden vision loss
Our comprehensive comparison of research and pharmaceutical peptides covers the broader landscape of formulation differences
